Results
|
12661.
|
|
|
12662.
|
|
|
12663.
|
|
|
12664.
|
|
|
12665.
|
|
|
12666.
|
|
|
12667.
|
|
|
12668.
|
|
|
12669.
|
|
|
12670.
|
|
|
12671.
|
|
|
12672.
|
|
|
12673.
|
|
|
12674.
|
|
|
12675.
|
|
|
12676.
|
|
|
12677.
|
|
|
12678.
|
A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer. [electronic resource] by
- Wiechno, Paweł
- Somer, Bradley G
- Mellado, Begoña
- Chłosta, Piotr L
- Cervera Grau, José Manuel
- Castellano, Daniel
- Reuter, Christoph
- Stöckle, Michael
- Kamradt, Jörn
- Pikiel, Joanna
- Durán, Ignacio
- Wedel, Steffen
- Callies, Sophie
- André, Valérie
- Hurt, Karla
- Brown, Jacqueline
- Lahn, Michael
- Heinrich, Bernhard
Producer: 20140820
In:
European urology vol. 65
Availability: No items available.
|
|
12679.
|
|
|
12680.
|
|